amitriptyline has been researched along with Fatty Liver in 2 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yaryura-Tobias, JA | 1 |
| Pinto, A | 1 |
| Neziroglu, F | 1 |
| Milner, G | 1 |
| Kakulas, BA | 1 |
2 other studies available for amitriptyline and Fatty Liver
| Article | Year |
|---|---|
Anorexia nervosa, diabetes mellitus, brain atrophy, and fatty liver.
Topics: Adult; Amitriptyline; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Behavior Therapy; Brain Di | 2001 |
The potentiation by amitriptyline of liver changes induced by ethanol in mice.
Topics: Administration, Oral; Amitriptyline; Animals; Antioxidants; Cytoplasm; Drug Synergism; Ethanol; Fatt | 1969 |